The conversion ensures that all hospital patients will be noninvasively monitored using the Masimo oximetry technology available providing immediate, real-time measurements that help clinicians more rapidly assess, diagnose, and treat patients.

The Hospital said that as part of the conversion, 51 noninvasive hemoglobin monitors have been installed in key care areas throughout the hospital allowing clinicians to noninvasively measure patient hemoglobin levels in seconds, without the pain and delay associated with traditionally invasive blood tests.

The system-wide conversion standardises all Staten Island University Hospital’s sites of care to Masimo technology, including two campuses and 714 hospital beds, which involved upgrading the hospital’s multi-parameter patient monitors, pulse oximeters, and sensors.

Michael O’Reilly, executive vice president of medical affairs at Masimo, said: “Staten Island University Hospital’s commitment to leverage state-of-the-art medical technology for the betterment of patient care was a driving force in their decision to upgrade their oximetry technology. Their system-wide conversion to Masimo provides an advanced technology platform offering noninvasive measurement capabilities they can use today with the ability to easily add new measurements in the future.”

Charles Vonfrolio, director of anesthesia at Staten Island University Hospital, said: “We wanted access to the most advanced noninvasive oximetry technologies available throughout our entire hospital system and that’s exactly what our conversion to Masimo enables.

“Masimo Rainbow SET capabilities provide real-time measurements and new clinical detail that expand patient monitoring beyond the traditional standard of care. With continuous tracking and trending of hemoglobin, fluid status, oxygen, carbon monoxide, and methemoglobin blood levels, we’re able to make better healthcare decisions, faster.”

Masimo offers the upgradable pulse oximetry technology platform Masimo Rainbow SET Pulse CO-Oximetry that allows hospitals to add noninvasive blood constituent measurement capabilities that previously required invasive procedures.